These findings support the use of Epithalon as a probe for skin biology, wound-healing, and extracellular matrix maintenance in preclinical systems
The most common side effects include nausea (50-60% of users, most common during dose escalation but usually resolves within 2-4 weeks at each dose level), vomiting (25-30%, often transient and manageable), diarrhea (25-30%, usually mild and self-limiting), constipation (15-20%, manageable with dietary adjustments), and decreased appetite (20-30%, which is a desired effect but can be intense first)
Resistance training and high protein intake become non-negotiable when using tirzepatide for substantial weight loss
This results in smoother texture, fewer wrinkles, and reduced sagging
The peptide enhances all phases of the healing process, including inflammatory phase modulation , proliferative phase stimulation , and remodeling phase optimization